post-transplant lymphoproliferative disorder

Also found in: Wikipedia.

post-transplant lymphoproliferative disorder

A family of Epstein-Barr virus-associated lymphoid expansions with a range of histologies, from infectious mononucleosis-like lymphoid hyperplasia to monoclonal neoplasms, that may not be classifiable as specific types of non-Hodgkin lymphoma, even if typical genetic defects are present. Monoclonal post-transplant lymphoproliferative disorders (PTLDs) do not regress when immunosuppression is withdrawn. PTLD occurs in 1–10% of organ transplant recipients; most cases that occur in solid organ recipients are of host origin.

Post-transplant patients at risk for PTLD can be identified by detecting expression (as small mRNA) of the EBER-1 gene.

Malignant features may regress with reduced immunosuppression.
References in periodicals archive ?
Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients--BCSH and BTS Guidelines.
Post-transplant lymphoproliferative disorder (PTLD) occurs in 1-10% of patients undergoing solid-organ transplantation and presents predominantly in the first year.
Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: a case-control study.
The virus can then reawaken and drive the development of B cell cancers like AIDS-associated B cell lymphoma and post-transplant lymphoproliferative disorder.
But while recovering from the transplant, a PET scan revealed she had developed post-transplant lymphoproliferative disorder (PTLD), a condition which can lead to cancer.
Post-transplant lymphoproliferative disorder (PTLD) can be attributed to an acute infection with EBV following transplantation.
A new Guideline detailing diagnosis, workup, and treatment options for Post-Transplant Lymphoproliferative Disorder (PTLD), as well as stronger recommendations for therapies in follicular lymphoma, topped the list of highlights in a presentation of the updated NCCN Guidelines([TM]) for Non-Hodgkin's Lymphomas (NHL).
Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients.
A recent decrease in time to development of monomorphous and polymorphous post-transplant lymphoproliferative disorder.
Cytologic features of post-transplant lymphoproliferative disorder.
EBV infection is associated with development of post-transplant lymphoproliferative disorder (PTLD), a serious complication of bone marrow or solid-organ transplantation in which uncontrolled growth of lymphatic tissue can become life-threatening.

Full browser ?